Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of revenue | 1.02%86.55M | 85.67M | ||||||||
| Gross profit | -13.90%43.19M | 50.16M | ||||||||
| Operating expense | 16.67%1.02M | -9.84%788K | 1.66%859K | -11.65%4.64M | -10.29%2.04M | -11.43%876K | -18.24%874K | -7.55%845K | 16.09%5.25M | 16.26%2.27M |
| Selling and administrative expenses | 15.09%1.02M | -9.84%788K | 1.66%859K | -11.42%4.65M | -10.29%2.04M | -10.12%888K | -18.24%874K | -7.65%845K | 15.22%5.25M | 16.26%2.27M |
| -General and administrative expense | 15.09%1.02M | -9.84%788K | 1.66%859K | -11.42%4.65M | -10.29%2.04M | -10.12%888K | -18.24%874K | -7.65%845K | 15.22%5.25M | 16.26%2.27M |
| Total other operating income | ---- | ---- | ---- | --12K | --0 | 1,300.00%12K | --0 | --0 | --0 | --0 |
| Operating profit | -16.67%-1.02M | 9.84%-788K | -1.66%-859K | 11.65%-4.64M | 10.29%-2.04M | 11.43%-876K | 18.24%-874K | 7.55%-845K | -16.09%-5.25M | -16.26%-2.27M |
| Net non-operating interest income expense | 1K | 53K | 469.23%74K | -47.06%45K | -45.88%46K | 0 | 0 | 1,400.00%13K | -76.12%85K | 8,600.00%85K |
| Non-operating interest income | --1K | --53K | 435.71%75K | -46.51%46K | -45.88%46K | --0 | --0 | --14K | -76.11%86K | --85K |
| Non-operating interest expense | --0 | --0 | 0.00%1K | 0.00%1K | --0 | --0 | --0 | 0.00%1K | -75.00%1K | --0 |
| Net investment income | ||||||||||
| Gain/Loss on financial instruments designated as cash flow hedges | ||||||||||
| Gain/Loss on derecognition of available-for-sale financial assets | ||||||||||
| Income from associates and other participating interests | -29.47%-3.01M | -243.70%-6.99M | -1,324.91%-3.39M | 128.63%5.05M | 335.21%2.24M | 57.88%-2.33M | 182.11%4.87M | 104.13%277K | -226.18%-17.64M | 104.59%514K |
| Special income /charges | ||||||||||
| Other non-operating income /expenses | ||||||||||
| Income before tax | -25.94%-4.04M | -293.59%-7.73M | -652.79%-4.18M | 102.02%461K | 114.51%243K | 50.82%-3.2M | 157.06%3.99M | 92.71%-555K | -220.69%-22.8M | -110.95%-1.68M |
| Income tax | 0 | -14.38%3.99M | 0 | 0 | 0 | -4.67M | 4.67M | 0 | 0 | |
| Net income | -25.94%-4.04M | -293.59%-7.73M | -652.79%-4.18M | 102.02%461K | 114.51%243K | 50.82%-3.2M | 157.06%3.99M | 92.71%-555K | -220.49%-22.8M | -110.93%-1.68M |
| Net income continuous operations | -25.94%-4.04M | -293.59%-7.73M | -652.79%-4.18M | 102.02%461K | 114.51%243K | 50.82%-3.2M | 157.06%3.99M | 92.71%-555K | -220.49%-22.8M | -110.93%-1.68M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -25.94%-4.04M | -293.59%-7.73M | -652.79%-4.18M | 102.02%461K | 114.51%243K | 50.82%-3.2M | 157.06%3.99M | 92.71%-555K | -220.49%-22.8M | -110.93%-1.68M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -25.94%-4.04M | -293.59%-7.73M | -652.79%-4.18M | 102.02%461K | 114.51%243K | 50.82%-3.2M | 157.06%3.99M | 92.71%-555K | -220.49%-22.8M | -110.93%-1.68M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -25.32%-0.0198 | -293.88%-0.038 | -659.26%-0.0205 | 102.05%0.0023 | 114.63%0.0012 | 50.63%-0.0158 | 156.98%0.0196 | 92.78%-0.0027 | -220.54%-0.1121 | -110.89%-0.0082 |
| Diluted earnings per share | -25.32%-0.0198 | -293.88%-0.038 | -659.26%-0.0205 | 102.05%0.0023 | 114.63%0.0012 | 50.63%-0.0158 | 156.98%0.0196 | 92.78%-0.0027 | -220.54%-0.1121 | -110.89%-0.0082 |
| Dividend per share | ||||||||||
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |